Clinical Updates
Re-Launch of Generic Astepro
The generic equivalent of Astepro (azelastine) has just been re-launched, following FDA approval. Astepro is…
DEA Finalizes Rule to Schedule Tramadol
On July 2, 2014, the Drug Enforcement Administration (DEA) published in the Federal Register the…
Launch of Generic Testim® 1% gel
The generic equivalent of Testim® 1% gel (testosterone gel) has just been released, following FDA…
Launch of Generic Actonel 150mg
The generic equivalent of Actonel 150mg (risendronate sodium tablets) has just been released, following FDA…
Launch of Generic Pennsaid 1.5%
The generic equivalent of Pennsaid 1.5% (diclofenac sodium topical solution) has just been released, following…
New Medication Update: Nexium® 24HR
Pfizer, Inc. has announced the introduction in the U.S. of over-the-counter (OTC) Nexium® 24HR. The…
Launch of Generic Exalgo® Extended Release Tablets
The generic equivalent of Exalgo® extended release tablets (hydromorphone hydrochloride) has just been released, following…
FDA Recommends Decreased Dosage Of Lunesta
The U.S. Food and Drug Administration (FDA) has released a Safety Announcement which states: “The…
Launch of Generic Lovaza® Capsules
The generic equivalent of Lovaza® capsules (omega-3-acid ethyl esters) has just been released, following FDA…
Lunesta Generic Release
The generic equivalent of Lunesta tablets (eszopiclone) has been released, following FDA approval. Lunesta is…
